메뉴 건너뛰기




Volumn 7, Issue 9, 2012, Pages

Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia: A Possible Association between Survival Rate and ITPA Polymorphism

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; MULTIDRUG RESISTANCE PROTEIN 1; THIOPURINE METHYLTRANSFERASE; THYMIDYLATE SYNTHASE; VITAMIN D RECEPTOR;

EID: 84866722399     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045558     Document Type: Article
Times cited : (37)

References (39)
  • 1
    • 40749150603 scopus 로고    scopus 로고
    • Acute lymphoblastic leukaemia
    • Pui CH, Robison LL, Look AT, (2008) Acute lymphoblastic leukaemia. Lancet 371: 1030-1043.
    • (2008) Lancet , vol.371 , pp. 1030-1043
    • Pui, C.H.1    Robison, L.L.2    Look, A.T.3
  • 2
    • 0037421590 scopus 로고    scopus 로고
    • Pharmacogenomics-drug disposition, drug targets, and side effects
    • Evans WE, McLeod HL, (2003) Pharmacogenomics-drug disposition, drug targets, and side effects. N Engl J Med 348: 538-549.
    • (2003) N Engl J Med , vol.348 , pp. 538-549
    • Evans, W.E.1    McLeod, H.L.2
  • 3
    • 0033966455 scopus 로고    scopus 로고
    • Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study
    • Pollock BH, DeBaun MR, Camitta BM, Shuster JJ, Ravindranath Y, et al. (2000) Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol 18: 813-823.
    • (2000) J Clin Oncol , vol.18 , pp. 813-823
    • Pollock, B.H.1    DeBaun, M.R.2    Camitta, B.M.3    Shuster, J.J.4    Ravindranath, Y.5
  • 4
    • 38549100505 scopus 로고    scopus 로고
    • Mixed Race: Understanding Difference in the Genome Era
    • Phillips EM, Odunlami AO, Bonham VL, (2007) Mixed Race: Understanding Difference in the Genome Era. Soc Forces 86: 795-820.
    • (2007) Soc Forces , vol.86 , pp. 795-820
    • Phillips, E.M.1    Odunlami, A.O.2    Bonham, V.L.3
  • 5
    • 0038811747 scopus 로고    scopus 로고
    • Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881
    • Hutchinson RJ, Gaynon PS, Sather H, Bertolone SJ, Cooper HA, et al. (2003) Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881. J Clin Oncol 21: 1790-1797.
    • (2003) J Clin Oncol , vol.21 , pp. 1790-1797
    • Hutchinson, R.J.1    Gaynon, P.S.2    Sather, H.3    Bertolone, S.J.4    Cooper, H.A.5
  • 6
    • 0036464595 scopus 로고    scopus 로고
    • Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
    • Lange BJ, Bostrom BC, Cherlow JM, Sensel MG, La MK, et al. (2002) Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 99: 825-833.
    • (2002) Blood , vol.99 , pp. 825-833
    • Lange, B.J.1    Bostrom, B.C.2    Cherlow, J.M.3    Sensel, M.G.4    La, M.K.5
  • 7
    • 13444270315 scopus 로고    scopus 로고
    • Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy
    • Broxson EH, Dole M, Wong R, Laya BF, Stork L, (2005) Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy. Pediatr Blood Cancer 44: 226-231.
    • (2005) Pediatr Blood Cancer , vol.44 , pp. 226-231
    • Broxson, E.H.1    Dole, M.2    Wong, R.3    Laya, B.F.4    Stork, L.5
  • 8
    • 76749095066 scopus 로고    scopus 로고
    • Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report
    • Gaynon PS, Angiolillo AL, Carroll WL, Nachman JB, Trigg ME, et al. (2010) Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report. Leukemia 24: 285-297.
    • (2010) Leukemia , vol.24 , pp. 285-297
    • Gaynon, P.S.1    Angiolillo, A.L.2    Carroll, W.L.3    Nachman, J.B.4    Trigg, M.E.5
  • 9
    • 74349121724 scopus 로고    scopus 로고
    • Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status
    • Stocco G, Crews KR, Evans WE, (2010) Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status. Expert Opin Drug Saf 9: 23-37.
    • (2010) Expert Opin Drug Saf , vol.9 , pp. 23-37
    • Stocco, G.1    Crews, K.R.2    Evans, W.E.3
  • 10
    • 58449117037 scopus 로고    scopus 로고
    • Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia
    • Stocco G, Cheok MH, Crews KR, Dervieux T, French D, et al. (2009) Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia. Clin Pharmacol Ther 85: 164-172.
    • (2009) Clin Pharmacol Ther , vol.85 , pp. 164-172
    • Stocco, G.1    Cheok, M.H.2    Crews, K.R.3    Dervieux, T.4    French, D.5
  • 11
    • 20444419044 scopus 로고    scopus 로고
    • Pharmacogenetics of outcome in children with acute lymphoblastic leukemia
    • Rocha JC, Cheng C, Liu W, Kishi S, Das S, et al. (2005) Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 105: 4752-4758.
    • (2005) Blood , vol.105 , pp. 4752-4758
    • Rocha, J.C.1    Cheng, C.2    Liu, W.3    Kishi, S.4    Das, S.5
  • 12
    • 35648982482 scopus 로고    scopus 로고
    • Pharmacogenetics of acute lymphoblastic leukemia treatment response
    • Cunningham L, Aplenc R, (2007) Pharmacogenetics of acute lymphoblastic leukemia treatment response. Expert Opin Pharmacother 8: 2519-2531.
    • (2007) Expert Opin Pharmacother , vol.8 , pp. 2519-2531
    • Cunningham, L.1    Aplenc, R.2
  • 14
    • 0033253070 scopus 로고    scopus 로고
    • Steroid hormone receptors: evolution, ligands, and molecular basis of biologic function
    • Whitfield GK, Jurutka PW, Haussler CA, Haussler MR, (1999) Steroid hormone receptors: evolution, ligands, and molecular basis of biologic function. J Cell Biochem Suppl 32-33: 110-122.
    • (1999) J Cell Biochem Suppl , vol.32-33 , pp. 110-122
    • Whitfield, G.K.1    Jurutka, P.W.2    Haussler, C.A.3    Haussler, M.R.4
  • 15
    • 0033135738 scopus 로고    scopus 로고
    • Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia
    • Relling MV, Hancock ML, Boyett JM, Pui CH, Evans WE, (1999) Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood 93: 2817-2823.
    • (1999) Blood , vol.93 , pp. 2817-2823
    • Relling, M.V.1    Hancock, M.L.2    Boyett, J.M.3    Pui, C.H.4    Evans, W.E.5
  • 16
    • 0021838288 scopus 로고
    • The cellular pharmacology of methotrexate
    • Goldman ID, Matherly LH, (1985) The cellular pharmacology of methotrexate. Pharmacol Ther 28: 77-102.
    • (1985) Pharmacol Ther , vol.28 , pp. 77-102
    • Goldman, I.D.1    Matherly, L.H.2
  • 17
    • 0035878867 scopus 로고    scopus 로고
    • Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors
    • Wang W, Marsh S, Cassidy J, McLeod HL, (2001) Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors. Cancer Res 61: 5505-5510.
    • (2001) Cancer Res , vol.61 , pp. 5505-5510
    • Wang, W.1    Marsh, S.2    Cassidy, J.3    McLeod, H.L.4
  • 18
    • 0036143203 scopus 로고    scopus 로고
    • Recent insights into the mechanism of glucocorticosteroid-induced apoptosis
    • Distelhorst CW, (2002) Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 9: 6-19.
    • (2002) Cell Death Differ , vol.9 , pp. 6-19
    • Distelhorst, C.W.1
  • 19
    • 43049102346 scopus 로고    scopus 로고
    • TotalPlex gene amplification using bulging primers for pharmacogenetic analysis of acute lymphoblastic leukemia
    • Kang HJ, Oh Y, Chun SM, Seo YJ, Shin HY, et al. (2008) TotalPlex gene amplification using bulging primers for pharmacogenetic analysis of acute lymphoblastic leukemia. Mol Cell Probes 22: 193-200.
    • (2008) Mol Cell Probes , vol.22 , pp. 193-200
    • Kang, H.J.1    Oh, Y.2    Chun, S.M.3    Seo, Y.J.4    Shin, H.Y.5
  • 20
    • 44849117242 scopus 로고    scopus 로고
    • ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study
    • Huang MY, Fang WY, Lee SC, Cheng TL, Wang JY, et al. (2008) ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study. BMC Cancer 8: 50.
    • (2008) BMC Cancer , vol.8 , pp. 50
    • Huang, M.Y.1    Fang, W.Y.2    Lee, S.C.3    Cheng, T.L.4    Wang, J.Y.5
  • 21
    • 12144285961 scopus 로고    scopus 로고
    • Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase)
    • Marinaki AM, Ansari A, Duley JA, Arenas M, Sumi S, et al. (2004) Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics 14: 181-187.
    • (2004) Pharmacogenetics , vol.14 , pp. 181-187
    • Marinaki, A.M.1    Ansari, A.2    Duley, J.A.3    Arenas, M.4    Sumi, S.5
  • 22
    • 79956344946 scopus 로고    scopus 로고
    • Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis
    • Gao LB, Pan XM, Li LJ, Liang WB, Bai P, et al. (2011) Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis. PLoS One 6: e20157.
    • (2011) PLoS One , vol.6
    • Gao, L.B.1    Pan, X.M.2    Li, L.J.3    Liang, W.B.4    Bai, P.5
  • 23
    • 77953744553 scopus 로고    scopus 로고
    • Effect of CYP2D6, CYP3A5, and MDR1 genetic polymorphisms on the pharmacokinetics of risperidone and its active moiety
    • Xiang Q, Zhao X, Zhou Y, Duan JL, Cui YM, (2010) Effect of CYP2D6, CYP3A5, and MDR1 genetic polymorphisms on the pharmacokinetics of risperidone and its active moiety. J Clin Pharmacol 50: 659-666.
    • (2010) J Clin Pharmacol , vol.50 , pp. 659-666
    • Xiang, Q.1    Zhao, X.2    Zhou, Y.3    Duan, J.L.4    Cui, Y.M.5
  • 24
    • 34250326888 scopus 로고    scopus 로고
    • MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation
    • Wu L, Xu X, Shen J, Xie H, Yu S, et al. (2007) MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation. J Surg Oncol 96: 62-68.
    • (2007) J Surg Oncol , vol.96 , pp. 62-68
    • Wu, L.1    Xu, X.2    Shen, J.3    Xie, H.4    Yu, S.5
  • 25
    • 16844372846 scopus 로고    scopus 로고
    • Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia
    • Aplenc R, Thompson J, Han P, La M, Zhao H, et al. (2005) Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Cancer Res 65: 2482-2487.
    • (2005) Cancer Res , vol.65 , pp. 2482-2487
    • Aplenc, R.1    Thompson, J.2    Han, P.3    La, M.4    Zhao, H.5
  • 26
    • 33644840600 scopus 로고    scopus 로고
    • Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy
    • Cheok MH, Evans WE, (2006) Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy. Nat Rev Cancer 6: 117-129.
    • (2006) Nat Rev Cancer , vol.6 , pp. 117-129
    • Cheok, M.H.1    Evans, W.E.2
  • 27
    • 84866631524 scopus 로고    scopus 로고
    • Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia
    • Adam de Beaumais T, Jacqz-Aigrain E, (2012) Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia. Eur J Clin Pharmacol.
    • (2012) Eur J Clin Pharmacol
    • Adam de Beaumais, T.1    Jacqz-Aigrain, E.2
  • 28
    • 20144365645 scopus 로고    scopus 로고
    • Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia
    • Stanulla M, Schaeffeler E, Flohr T, Cario G, Schrauder A, et al. (2005) Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA 293: 1485-1489.
    • (2005) JAMA , vol.293 , pp. 1485-1489
    • Stanulla, M.1    Schaeffeler, E.2    Flohr, T.3    Cario, G.4    Schrauder, A.5
  • 29
    • 84860292912 scopus 로고    scopus 로고
    • Epistatic interactions between thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) variations determine 6-mercaptopurine toxicity in Indian children with acute lymphoblastic leukemia
    • Dorababu P, Nagesh N, Linga VG, Gundeti S, Kutala VK, et al. (2012) Epistatic interactions between thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) variations determine 6-mercaptopurine toxicity in Indian children with acute lymphoblastic leukemia. Eur J Clin Pharmacol 68: 379-387.
    • (2012) Eur J Clin Pharmacol , vol.68 , pp. 379-387
    • Dorababu, P.1    Nagesh, N.2    Linga, V.G.3    Gundeti, S.4    Kutala, V.K.5
  • 30
    • 0037433052 scopus 로고    scopus 로고
    • Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions
    • Hahn LW, Ritchie MD, Moore JH, (2003) Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19: 376-382.
    • (2003) Bioinformatics , vol.19 , pp. 376-382
    • Hahn, L.W.1    Ritchie, M.D.2    Moore, J.H.3
  • 31
    • 0037310257 scopus 로고    scopus 로고
    • Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity
    • Ritchie MD, Hahn LW, Moore JH, (2003) Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 24: 150-157.
    • (2003) Genet Epidemiol , vol.24 , pp. 150-157
    • Ritchie, M.D.1    Hahn, L.W.2    Moore, J.H.3
  • 32
    • 79960521621 scopus 로고    scopus 로고
    • Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children
    • de Wildt SN, (2011) Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children. Expert Opin Drug Metab Toxicol 7: 935-948.
    • (2011) Expert Opin Drug Metab Toxicol , vol.7 , pp. 935-948
    • de Wildt, S.N.1
  • 33
    • 2442573750 scopus 로고    scopus 로고
    • Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age
    • Ganiere-Monteil C, Medard Y, Lejus C, Bruneau B, Pineau A, et al. (2004) Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age. Eur J Clin Pharmacol 60: 89-96.
    • (2004) Eur J Clin Pharmacol , vol.60 , pp. 89-96
    • Ganiere-Monteil, C.1    Medard, Y.2    Lejus, C.3    Bruneau, B.4    Pineau, A.5
  • 35
    • 80051677030 scopus 로고    scopus 로고
    • Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C
    • Tanaka Y, Kurosaki M, Nishida N, Sugiyama M, Matsuura K, et al. (2011) Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C. Hum Mol Genet 20: 3507-3516.
    • (2011) Hum Mol Genet , vol.20 , pp. 3507-3516
    • Tanaka, Y.1    Kurosaki, M.2    Nishida, N.3    Sugiyama, M.4    Matsuura, K.5
  • 36
    • 77952034227 scopus 로고    scopus 로고
    • A novel C53/LZAP-interacting protein regulates stability of C53/LZAP and DDRGK domain-containing Protein 1 (DDRGK1) and modulates NF-kappaB signaling
    • Wu J, Lei G, Mei M, Tang Y, Li H, (2010) A novel C53/LZAP-interacting protein regulates stability of C53/LZAP and DDRGK domain-containing Protein 1 (DDRGK1) and modulates NF-kappaB signaling. J Biol Chem 285: 15126-15136.
    • (2010) J Biol Chem , vol.285 , pp. 15126-15136
    • Wu, J.1    Lei, G.2    Mei, M.3    Tang, Y.4    Li, H.5
  • 37
    • 58449111231 scopus 로고    scopus 로고
    • The increasing complexity of mercaptopurine pharmacogenomics
    • Marsh S, Van Booven DJ, (2009) The increasing complexity of mercaptopurine pharmacogenomics. Clin Pharmacol Ther 85: 139-141.
    • (2009) Clin Pharmacol Ther , vol.85 , pp. 139-141
    • Marsh, S.1    van Booven, D.J.2
  • 38
    • 0142120075 scopus 로고    scopus 로고
    • Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia
    • Kadan-Lottick NS, Ness KK, Bhatia S, Gurney JG, (2003) Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA 290: 2008-2014.
    • (2003) JAMA , vol.290 , pp. 2008-2014
    • Kadan-Lottick, N.S.1    Ness, K.K.2    Bhatia, S.3    Gurney, J.G.4
  • 39
    • 0037105454 scopus 로고    scopus 로고
    • Racial and ethnic differences in survival of children with acute lymphoblastic leukemia
    • Bhatia S, Sather HN, Heerema NA, Trigg ME, Gaynon PS, et al. (2002) Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 100: 1957-1964.
    • (2002) Blood , vol.100 , pp. 1957-1964
    • Bhatia, S.1    Sather, H.N.2    Heerema, N.A.3    Trigg, M.E.4    Gaynon, P.S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.